Amwill Health

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0U2L01017
  • NSEID:
  • BSEID: 544353
INR
43.06
-1.49 (-3.34%)
BSENSE

Sep 23, 02:18 PM

BSE+NSE Vol: 8400

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 12.10% vs -7.66% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 11.51% vs -30.09% in Mar 2025

stock-summary

Interest

No Interest in the last few periods;

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 6.44% vs -14.16% in Mar 2025

Compare Profit and Loss Results of Amwill Health
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
45.00
181.00
-136.00
-75.14%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
45.00
181.00
-136.00
-75.14%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
98.00
-98.00
-100.00%
Power & Fuel Cost
0.00
10.00
-10.00
-100.00%
Employee Cost
8.00
17.00
-9.00
-52.94%
Operating Expenses
13.00
4.00
9.00
225.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
7.00
23.00
-16.00
-69.57%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
4.00
-4.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
32.00
164.00
-132.00
-80.49%
Operating Profit (PBDIT) excl Other Income
12.00
17.00
-5.00
-29.41%
Other Income
2.00
1.00
1.00
100.00%
Operating Profit (PBDIT)
15.00
19.00
-4.00
-21.05%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
15.00
18.00
-3.00
-16.67%
Depreciation
0.00
6.00
-6.00
-100.00%
Profit Before Taxation & Exceptional Items
15.00
11.00
4.00
36.36%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
15.00
11.00
4.00
36.36%
Provision for Tax
3.00
3.00
0.00
0.00%
Profit After Tax
11.00
8.00
3.00
37.50%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
12.00
39.00
-27.00
-69.23%
Profit Available for appropriations
23.00
47.00
-24.00
-51.06%
Appropriations
23.00
47.00
-24.00
-51.06%
Equity Dividend (%)
5%
25%
-20.00
Earnings Per Share
5.71
6.06
-0.35
-5.78%
Profit And Loss - Net Sales
Net Sales 45.49 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 12.10% vs -7.66% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 12.99 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 11.51% vs -30.09% in Mar 2025

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2026

Figures in Cr
stock-summary

No Interest in the last few periods;

Profit And Loss - Profit After Tax
Profit After Tax 11.42 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 6.44% vs -14.16% in Mar 2025